Secondary Logo

Journal Logo

October 2006 - Volume 61 - Issue 10
pp: 617-684


Preconception and Prenatal Care


Management of Labor, Delivery, and the Puerperium


Obstetrics (Delivery Complication)


Drugs in Pregnancy (Teratology)


Obstetric Ultrasound


Prenatal Genetics


Medical Complication of Pregnancy (Thrombocytopenia)



Operative Gynecology


Office Gynecology


Gynecologic Oncology


Pelvic Lymph Node Count is an Important Prognostic Variable for FIGO Stage I and II Endometrial Carcinoma With High-Risk Histology

Lutman, Christopher V.; Havrilesky, Laura J.; Cragun, Janiel M.; More

Obstetrical & Gynecological Survey. 61(10):642-644, October 2006.

Normal and Abnormal Menstrual Function


Infertility/Reproductive Technologies


Menopause


Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Vogel, Victor G.; Costantino, Joseph P.; Wickerham, D Lawrence; More

Obstetrical & Gynecological Survey. 61(10):650, October 2006.

Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Land, Stephanie R.; Wickerham, D Lawrence; Costantino, Joseph P.; More

Obstetrical & Gynecological Survey. 61(10):651-653, October 2006.



CATEGORY 1 CME REVIEW ARTICLES 28, 29, AND 30: CME REVIEW ARTICLE 28


CATEGORY 1 CME REVIEW ARTICLES 28, 29, AND 30: CME REVIEW ARTICLE 29


CATEGORY 1 CME REVIEW ARTICLES 28, 29, AND 30: CME REVIEW ARTICLE 30


EXAM Answers for August 2006: CME Exam Answers


CME Program Exam and Answer Sheet: CME Exam


Exam Answer Sheet


Show: